InvestorsHub Logo
Followers 646
Posts 144549
Boards Moderated 1
Alias Born 05/19/2007

Re: None

Friday, 02/03/2017 3:44:15 PM

Friday, February 03, 2017 3:44:15 PM

Post# of 9818
OBMP is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a proprietary Vaccine Technology that is designed to stimulate the immune system to attack its own cancer while not hurting the patient. Our lead product, ProscaVax® is scheduled to commence a Phase 2 clinical study in 2016. OncBioMune also has a portfolio of targeted therapies, some of which are biosimilars to blockbuster drugs. OncBioMune is headquartered in Baton Rouge, LA. Learn more at: http://oncbiomune.com


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent THER News